When a woman is diagnosed with a precancerous lesion of the cervix, clinicians and patients alike tend to focus their attention on that single finding. Yet the lower genital tract is a contiguous field, and the same persistent high-risk human papillomavirus (HPV) infection that drives cervical intraepithelial neoplasia can simultaneously fuel lesions in the vagina and vulva. A new retrospective case-control study from China, published in BMC Cancer, provides some of the most granular data yet on who develops these multicentric lesions and what characteristics set them apart from patients whose disease remains confined to the cervix. The findings carry an uncomfortable but clinically important message: concurrent vaginal and vulvar precancerous lesions are far more common than many screening programs assume, particularly among women with high-grade cervical disease, and a constellation of demographic, behavioral, and virological factors can help identify the patients at greatest risk.
The study, led by Qi Chen and Yuqing Chu with corresponding author Yang Lin, drew on clinical records from a single center and compared 362 patients who had histologically confirmed cervical lesions together with concurrent vaginal and/or vulvar intraepithelial neoplasia identified during the same diagnostic episode against 391 patients whose lesions were confined to the cervix. All diagnoses rested on histopathology rather than cytology alone, which is crucial because vulvovaginal lesions are notoriously difficult to detect through routine Pap-based screening. The researchers then deployed multivariable logistic regression to isolate the characteristics independently associated with multicentric involvement, separating patients with low-grade disease from those with high-grade disease, and built exploratory prediction models whose performance they assessed using receiver operating characteristic, calibration, and decision curve analyses.
The headline numbers are striking. Among patients whose cervical lesions were high-grade, 34.75 percent had concurrent high-grade vaginal squamous intraepithelial lesions, compared with just 12.30 percent of patients with low-grade cervical lesions, a difference that was highly statistically significant at P < 0.001. High-grade vulvar lesions followed a similar pattern, present in 20.34 percent of the high-grade cervical group versus 10.25 percent of the low-grade group (P = 0.031). In other words, roughly one in three women with high-grade cervical disease in this cohort harbored a clinically significant vaginal lesion, and one in five had a significant vulvar lesion. These figures reinforce what a growing body of literature has suggested: that evaluating only the cervix in a patient with an abnormal cervical screening result risks missing precancerous disease elsewhere in the lower genital tract, lesions that can progress to invasive vaginal or vulvar cancer if left unaddressed.
The virological data added important nuance. An HPV DNA signal of at least 500 RLU/CO on hybrid-capture testing, a proxy for a high viral load, emerged as an independent risk factor for multicentric involvement at both disease grades. HPV16/18-group positivity, which corresponds to the two highest-risk viral types responsible for the majority of HPV-driven cancers, was likewise independently associated with multicentric disease. For the high-grade group specifically, persistent HPV infection lasting one year or longer added further risk, suggesting that the duration of viral carriage, not merely its intensity, matters when it comes to seeding lesions across multiple anatomical sites. This fits with the biological model of HPV field carcinogenesis, in which a persistent, high-burden infection of the transformation zone and adjacent epithelia gives rise to independent but synchronous lesions.
Behavioral and demographic factors painted a complementary picture. For high-grade multicentric involvement, menopause and an early sexual debut at age 18 or younger were both independently associated with risk, alongside the viral factors mentioned above. Menopausal status is biologically plausible as a contributor: estrogen deficiency leads to vaginal epithelial atrophy and shifts in the local microbiome, which may impair mucosal immune defense and facilitate viral persistence and lesion progression in the vagina and vulva, sites where the transformation zone tissue is already vulnerable. Early sexual debut, meanwhile, extends the lifetime duration of HPV exposure and is a recognized risk factor for multicentric HPV-associated disease.
Perhaps the most provocative findings concern two protective factors. The absence of HPV vaccination was independently associated with multicentric involvement in both the low-grade and high-grade analyses, and the absence of partner circumcision was likewise independently linked to multicentric disease at both grades. The vaccination association is straightforward and expected, given that current prophylactic vaccines directly target HPV16 and HPV18 and prevent the persistent infections that seed multicentric lesions. The circumcision association is more interesting from a mechanistic standpoint. Male circumcision reduces the likelihood of HPV acquisition and transmission by removing the foreskin’s moist keratinized environment where the virus can persist, and studies have repeatedly shown lower HPV prevalence among circumcised men and their female partners. The present study adds to the evidence that this intervention, often discussed in the context of HIV prevention, also carries meaningful downstream benefits for cervical cancer prevention programs.
The research team did not stop at identifying risk factors; they also constructed exploratory multivariable prediction models to see how well a panel of these characteristics could distinguish multicentric from isolated cervical disease. The low-grade model achieved an area under the receiver operating characteristic curve of 0.703, which represents modest discrimination, while the high-grade model reached an AUC of 0.777, indicating moderate discrimination in the development dataset. For context, an AUC of 0.5 indicates performance no better than chance, while 1.0 represents perfect discrimination. These values suggest that the identified variables carry genuine predictive information, but the authors are careful to frame the models as hypothesis-generating tools rather than ready-for-clinic calculators. Because the study was retrospective and conducted at a single center, and because the models were not internally or externally validated in independent cohorts, they cannot yet be recommended for immediate clinical deployment or for causal inference.
The study’s limitations deserve honest acknowledgment. The retrospective, single-center design introduces the possibility of selection bias, since only patients who underwent comprehensive multisite assessment would have had concurrent lesions detected in the first place. Centers that routinely perform colposcopy of the vagina and vulva in addition to the cervix may identify more multicentric disease than centers that do not, meaning the true population prevalence of these concurrent lesions remains uncertain. The authors also note that all apparent model performance metrics were computed on the development dataset itself, without validation, so the reported AUCs may overestimate real-world accuracy. Still, the consistency of the viral-load, vaccination, and circumcision signals across both disease grades lends credibility to the core associations.
The clinical implications, while cautious, are concrete. The finding that high-grade cervical lesions are accompanied by concurrent high-grade vaginal and vulvar lesions in a substantial minority of patients strengthens the argument for comprehensive multisite assessment at the time of colposcopy, particularly for women with high-grade cervical cytology or histology. Routine examination of the vagina and vulva during colposcopic evaluation, coupled with biopsy of suspicious areas, could catch lesions that would otherwise be missed and allow treatment before progression to invasive cancer. The risk-factor profile may also help clinicians decide which patients warrant the most thorough multisite workup: postmenopausal women, those with HPV16 or HPV18 infections at high viral loads, women with infections persisting a year or longer, those whose partners are uncircumcised, and unvaccinated patients all fall into categories where heightened vigilance seems justified.
On a public health level, the study adds weight to the case for HPV vaccination, not only as a cervical cancer prevention measure but as a shield against the full spectrum of HPV-driven disease across the lower genital tract. It also highlights a secondary benefit of male circumcision that is rarely emphasized in cervical cancer screening discussions. As vaccination coverage expands globally, the incidence of multicentric intraepithelial neoplasia should decline, but in the meantime, and especially among older unvaccinated cohorts already past the recommended vaccination age, screening programs will need to look beyond the cervix to fulfill their promise. The authors of this study have provided a useful empirical foundation for that shift, along with a candid assessment of what their data can and cannot yet tell us. Future prospective, multicenter studies with independent model validation will determine whether these exploratory risk models can be refined into practical clinical decision tools, but the central message is already clear: the lower genital tract behaves as a single field at risk, and it should be assessed as one.
Subject of Research: Clinical factors associated with multicentric intraepithelial neoplasia of the lower genital tract (cervix, vagina, and vulva) among women with HPV-associated precancerous lesions
Subject of Research: Cancer
Article Title: Factors associated with multicentric intraepithelial neoplasia of the lower genital tract: a retrospective single-center case-control study
Article References: Chen, Q., Chu, Y., Shi, Z., Liu, S., Chen, G., Zheng, Y., & Lin, Y. (2026). Factors associated with multicentric intraepithelial neoplasia of the lower genital tract: a retrospective single-center case-control study. BMC Cancer. https://doi.org/10.1186/s12885-026-16915-1
Image Credits: AI Generated
DOI: 10.1186/s12885-026-16915-1
Keywords: Multicentric intraepithelial neoplasia, HPV16/18, HPV vaccination, Partner circumcision, High-grade squamous intraepithelial lesion, Vaginal intraepithelial neoplasia, Vulvar intraepithelial neoplasia, Persistent HPV infection, HPV viral load, Postmenopausal, Colposcopy, Lower genital tract
Cite Scienmag News
APA MLA Chicago
Nathaniel Bowman. (September 6, 2026). Risk factors for multicentric lower genital tract intraepithelial neoplasia revealed. Scienmag. https://scienmag.com/risk-factors-for-multicentric-lower-genital-tract-intraepithelial-neoplasia-revealed/
Nathaniel Bowman. “Risk factors for multicentric lower genital tract intraepithelial neoplasia revealed.” Scienmag, 6 September 2026, https://scienmag.com/risk-factors-for-multicentric-lower-genital-tract-intraepithelial-neoplasia-revealed/. Accessed 7 September 2026.
Nathaniel Bowman. “Risk factors for multicentric lower genital tract intraepithelial neoplasia revealed.” Scienmag. September 6, 2026. https://scienmag.com/risk-factors-for-multicentric-lower-genital-tract-intraepithelial-neoplasia-revealed/
Copy citation Download RIS
Tags: cervical intraepithelial neoplasiacervical precancer risk factorsclinical implications for screeningclinical predictors of multicentric lesionsconcurrent genital tract lesionsdemographic and behavioral risk factorsdemographic and behavioral risk factors for intraepithelial neoplasiaearly detection of multicentric intraepithelial neoplasiaepidemiology ofhigh-grade cervical diseaseHPV infection risk factorsHPV persistence and lesion developmentHPV persistent infectionHPV-associated multicentric intraepithelial neoplasiaHPV-driven neoplastic transformationHPV-related genital tract neoplasiaidentification of patients at high risk for multicentric lesionsMulticentric lower genital tract intraepithelial neoplasiaretrospective case-control study in Chinaretrospective case-control study on genital neoplasiascreening implications for lower genital tract neoplasiavaginal and vulvar intraepithelial neoplasiavaginal and vulvar precancerous lesions
